Castillo-TobÃas, I.; Berlanga, L.; Poblano, J.; RodrÃguez-Salazar, M.d.C.; Aguayo-Morales, H.; Cobos-Puc, L.E.
Fundamental Considerations of Targeted Drug Therapies for Breast Cancer. Future Pharmacol. 2023, 3, 686-707.
https://doi.org/10.3390/futurepharmacol3040043
AMA Style
Castillo-TobÃas I, Berlanga L, Poblano J, RodrÃguez-Salazar MdC, Aguayo-Morales H, Cobos-Puc LE.
Fundamental Considerations of Targeted Drug Therapies for Breast Cancer. Future Pharmacology. 2023; 3(4):686-707.
https://doi.org/10.3390/futurepharmacol3040043
Chicago/Turabian Style
Castillo-TobÃas, Ileana, Lia Berlanga, Joan Poblano, MarÃa del C. RodrÃguez-Salazar, Hilda Aguayo-Morales, and Luis E. Cobos-Puc.
2023. "Fundamental Considerations of Targeted Drug Therapies for Breast Cancer" Future Pharmacology 3, no. 4: 686-707.
https://doi.org/10.3390/futurepharmacol3040043
APA Style
Castillo-TobÃas, I., Berlanga, L., Poblano, J., RodrÃguez-Salazar, M. d. C., Aguayo-Morales, H., & Cobos-Puc, L. E.
(2023). Fundamental Considerations of Targeted Drug Therapies for Breast Cancer. Future Pharmacology, 3(4), 686-707.
https://doi.org/10.3390/futurepharmacol3040043